Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -71,067 | -51,537 | -34,765 | -17,128 | -51,853 |
| Depreciation Amortization | 3,884 | 2,910 | 1,096 | 546 | 1,617 |
| Accounts receivable | -668 | -444 | -302 | 543 | -865 |
| Other Working Capital | -2,853 | -3,844 | 1,216 | 735 | 107 |
| Other Operating Activity | 5,502 | 4,331 | 2,751 | 636 | 3,683 |
| Operating Cash Flow | $-65,202 | $-48,584 | $-30,004 | $-14,668 | $-47,311 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 39,729 | 39,729 | 34,729 | 16,256 | -40,337 |
| PPE Investments | -269 | -214 | -149 | -71 | -353 |
| Investing Cash Flow | $39,460 | $39,515 | $34,580 | $16,185 | $-40,690 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 20,000 |
| Common Stock Issued | 30,422 | 9,341 | 7,079 | 484 | 49,044 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -1,059 |
| Financing Cash Flow | $30,422 | $9,341 | $7,079 | $484 | $67,985 |
| Beginning Cash Position | 14,463 | 14,463 | 14,463 | 14,463 | 34,479 |
| End Cash Position | 19,143 | 14,735 | 26,118 | 16,464 | 14,463 |
| Net Cash Flow | $4,680 | $272 | $11,655 | $2,001 | $-20,016 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,202 | -48,584 | -30,004 | -14,668 | -47,311 |
| Capital Expenditure | -269 | -214 | -149 | -71 | -353 |
| Free Cash Flow | -65,471 | -48,798 | -30,153 | -14,739 | -47,664 |